Students and Residents Oral Session

[StO-01] Students and Residents Oral Session 01 Oral Presentation Award Session

Sat. May 22, 2021 10:15 AM - 10:50 AM Room 11 (ICC Kyoto 1F Room 157)

Chair：Kusunoki Susumu(Japan Community Health care Organization (JCHO))

+Add all to schedule

[StO-01-1] The impact of neuronal aging on APP processing in primary cultures of mouse cortical neurons

^○Yosuke Hishida², Kazuya Goto¹, Mizuki Matsumoto², Masakazu Miyamoto², Akira Kuzuya², Yasuto Tanabe¹, Ryosuke Takahashi² (1.Department of Regulation of Neurocognitive Disorders, Kyoto University Graduate School of Medicine, Japan, 2.Kyoto University Hospital Neurology, Japan)

[StO-01-2] Changes in serial CSF IgG index in herpesvirus meningoencephalitis

^○Mao Asakura¹, Yasuaki Mizutani², Koichi Kikuchi², Kazutaka Hayashi², Kunihisa Kato², Fumihiko Banno², Atsuhiro Higashi², Ryunosuke Nagao², Toshiki Maeda², Kenichiro Murate², Seiko Hirota², Tomomasa Ishikawa², Sayuri Shima², Akihiro Ueda², Mizuki Ito², Soichiro Ishimaru³, Yoshiki Kawamura³, Shinji Ito², Tetsushi Yoshikawa³, Hirohisa Watanabe² (1.Fujita Health University School of Medicine, Japan, 2.Department of Neurology, Fujita Health University School of Medecine, 3.Department of Pediatrics, Fujita Health University School of Medecine)

[StO-01-3] In vivo assessment of the expression of α-synuclein proteins in disruption of autophagy induction

^○Kanako Mae, Yoshitsugu Nakamura, Shigeki Arawaka (Osaka Medical and Pharmaceutical University Hospital, Japan)

[StO-01-4] Analysis of the mechanism of α-synuclein release stimulated by depolarization

^○Tomotaka Fukuse, Yoshitsugu Nakamura, Shigeki Arawaka (Osaka Medical and Pharmaceutical University Hospital, Japan)

[StO-01-5] Fatty acid-binding protein 3 is critical to take up alpha-synuclein fibrils in dopamine neurons

^○Tomoki Sekimori, Ichiro Kawahata, Haoyang Wang, Kohji Fukunaga (Department of Pharmacology, Graduate School of Pharmaceutical Sciences, Tohoku University, Japan)

[StO-01-6] Yips in Kyudo (Japanese archery): prevalence, classification, and risk factors

^○Seiichiro Nishio¹, Yuichi Hayashi², Shinei Kato², Yoya Ono², Masahiro Waza³, Yoichiro Nagao⁴, Akihiro Mukaino⁵, Shunya Nakane⁵, Takayoshi Shimohata² (1.Gifu University School of Medicine, Japan, 2.Department of Neurology, Gifu University Graduate School of Medicine, 3.Department of Neurology, Kakamigahara Rehabilitation Hospital, 4.Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, 5.Department of Molecular Neurology and Therapeutics, Kumamoto University Hospital)